No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Bio-View Ltd, founded in 2000 and headquartered in Rehovot, Israel, is a developer, manufacturer, and global distributor of advanced automated cell imaging and analysis systems. These sophisticated solutions are utilized by clinical and research laboratories worldwide, specifically in the fields of cytology, cytogenetics, and pathology. The company's extensive product lineup includes: Accord: A semi-automated fluorescent imaging and analysis workbench microscope station. Accord Plus: An automatic fluorescent imaging system capable of real-time scanning, analysis, and sorting of diverse FISH (Fluorescence In Situ Hybridization) samples. Allegro Plus: Another automatic fluorescent imaging system engineered to pinpoint various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. DUET-3: An imaging and analysis platform featuring an automated barcode reader, which streamlines the processing of multiple test types within a single scan batch. DeNovo: An automated scanning system dedicated to the precise detection, analysis, and characterization of circulating tumor cells found in peripheral blood. Solo Workstation & Solo Touch Workstation: These are offline and standalone workstations, respectively, providing advanced tools for reviewing and analyzing test results remotely from the microscope. SoloWeb: A comprehensive web-based solution that enables remote analysis, reporting, and expert consultation on cases scanned using Bio-View's systems. Furthermore, Bio-View Ltd has established a strategic partnership with ANGLE plc to jointly develop a liquid biopsy circulating tumor cell HER2 assay, specifically targeting breast cancer.
www.bioview.comNo one on the platform currently holds BIOV.TA.
No tracked institution reports a position in BIOV.TA as of their last filing.
No one on the platform has traded BIOV.TA yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BIOV.TABio-View Ltd | $79.90 | -0.99% | $11M | — |
| ALMD.TAAllmed Solutions Ltd | $31.30 | +0.32% | $30M | — |
| BOLT.TABioLight Life Sciences Ltd. | $295.90 | -2.57% | $27M | — |
| EMTC-M.TAElbit Medical Technologies Ltd | $22.20 | -7.50% | $20M | — |
| IDNT.TAIdenti Healthcare Ltd. | $185.90 | +3.28% | $27M | — |
| IMED.TAImed Infinity Medical-Limited Partnership | $109.60 | -5.11% | $7M | — |
| MRHL.TAMerchavia Holdings and Investments Ltd. | $144.20 | +0.00% | $30M | — |
Source: Financial Modeling Prep · peers by sector/industry